How much does a box of Dasatinib cost?

Dasatinib (Dasatinib) is an oral anti-leukemia drug that has significant efficacy in patients with chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). In 2024, dasatinib (Startax) will be launched in China and included in the medical insurance directory, making it easier for patients to purchase it domestically and obtain necessary treatment.

It is understood that the price of dasatinib (Startax) is about four to five thousand yuan per box, but the specific price and medical insurance reimbursement may vary depending on the region and hospital. Therefore, patients are advised to consult their local hospital pharmacy for more accurate pricing information and medical insurance reimbursement policies.

The price of foreign generic drugs of Dasatinib (Startax) is relatively low, about a few hundred yuan per box. These generic drugs are basically the same as the original drugs in terms of ingredients, but are more affordable. Nonetheless, there may be some risks involved in purchasing foreign generic drugs, such as lax quality control and unreliable import channels. Therefore, when choosing, patients should weigh the pros and cons and make a decision under the guidance of a doctor.

Whether they choose original drugs or generic drugs, patients should ensure they receive effective treatment and improve their quality of life. Treating leukemia is a long and difficult process, but with the continuous advancement of medical technology, patients can expect better treatment effects and survival rates.

In general, dasatinib (Tasatinib), as a targeted therapy, has proven its effectiveness in CML and some ALL patients, and provided these patients with better survival and quality of life. However, patients need to pay close attention to side effects when using dasatinib and follow their doctor's recommendations for treatment.